Jane Banerji
- Cancer Research
- Oncology
- Pulmonary and Respiratory Medicine
- Pathology and Forensic Medicine
- Genetics
- Co-authors
- Judith M. BlissLucy KilburnJames P. MordenChris HolcombeMaggie C.U. CheangAbigail EvansRaghavan VidyaCliona Kirwan
- Topics
- Breast Cancer Treatment Studies (10 papers)Cancer Treatment and Pharmacology (5 papers)Advanced Breast Cancer Therapies (3 papers)
- Partner nations
- United KingdomCanada
In The Last Decade
Jane Banerji
10 papers receiving 199 citations
Peers
Comparison fields: 5 of 37
- Cancer Research 155
- Oncology 134
- Pulmonary and Respiratory Medicine 64
- Pathology and Forensic Medicine 43
- Genetics 28
Countries citing papers authored by Jane Banerji
This map shows the geographic impact of Jane Banerji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Banerji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Banerji more than expected).
Fields of papers citing papers by Jane Banerji
This network shows the impact of papers produced by Jane Banerji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Banerji. The network helps show where Jane Banerji may publish in the future.
Co-authorship network of co-authors of Jane Banerji
This figure shows the co-authorship network connecting the top 25 collaborators of Jane Banerji. A scholar is included among the top collaborators of Jane Banerji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Banerji. Jane Banerji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 147 | |
| 3 | 15 | |
| 4 | 7 | |
| 5 | Accelerated versus standard epirubicin followed by CMF versus capecitabine as adjuvant therapy of breast cancer: results of the randomised UK TACT2 trial (CRUK/05/19) | 0 |
| 6 | 3 | |
| 7 | 8 | |
| 8 | 6 | |
| 9 | 9 | |
| 10 | 1 | |
| 11 | 2 |
About Jane Banerji
Jane Banerji is a scholar working on Cancer Research, Oncology and Economics and Econometrics, having authored 11 papers that have together received 204 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (10 papers), Cancer Treatment and Pharmacology (5 papers) and Advanced Breast Cancer Therapies (3 papers). The work is most often cited by research in Cancer Research (155 citations), Oncology (134 citations) and Pathology and Forensic Medicine (43 citations). Jane Banerji has collaborated with scholars based in United Kingdom and Canada. Frequent co-authors include Judith M. Bliss, Lucy Kilburn, James P. Morden, Chris Holcombe, Maggie C.U. Cheang, Abigail Evans, Raghavan Vidya, Cliona Kirwan, Andrew Dodson and Mitch Dowsett. Their work appears in journals such as Cancer Research, The Lancet Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.